Background Whether addition of corticosteroids to antibiotic treatment benefits patients with
community-acquired pneumonia who are not in intensive care units is unclear. We aimed to …

… Meijvis SCA, van de Garde EMW, Rijkers GT, Bos WJW (St. Antonius Hospital, Nieuwegein;
Utrecht University, Utrecht; St. Antonius Hospital, Nieuwegein; and Roosevelt Academy, …

The role of individual cytokines and polymorphisms in pneumonia has been described, but
the relationship between different cytokines and polymorphisms in relation to causative …

Background. Vitamin D plays a role in host defense against infection. Vitamin D deficiency is
common worldwide. The prognostic value of vitamin D levels in pneumonia is unknown. In …

Importance Patients with chronic kidney disease (CKD) are at high risk for cardiovascular
disease, but their systematic underrepresentation in cardiovascular randomized clinical trials (…

The influence of adjunctive corticosteroids on the cytokine response in community-acquired
pneumonia (CAP) is largely unknown. In this study, we analyzed the effect of …

Background Patients with chronic kidney disease (CKD) require a personalised strategy for
cardiovascular risk management (CVRM) to reduce their high risk of cardiovascular …

OBJECTIVES: Adjuvant dexamethasone treatment in patients with community-acquired
pneumonia (CAP) can reduce length of hospital stay. Whether there are subgroups of patients …

Recent initiation of proton-pump inhibitor (PPI) treatment may increase the risk of community-acquired
pneumonia (CAP), hypothetically by allowing colonisation of the oropharynx by …

Background Treatment of community acquired pneumonia (CAP) patients with antibiotics
before laboratory-confirmed diagnosis leads to loss of knowledge on the causative bacterial …